Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

ClinicalTrials.gov ID: NCT00939783

Public ClinicalTrials.gov record NCT00939783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon (PF 01913539) In Patients With Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the long-term safety and tolerability of Dimebon in patients with Alzheimer's disease.

Study identification

NCT ID
NCT00939783
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
649 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Aug 2010 (Actual)
Completion
Aug 2010 (Actual)
Last update posted
Nov 14, 2012

2009 – 2010

United States locations

U.S. sites
84
U.S. states
32
U.S. cities
80
Facility City State ZIP Site status
Pfizer Investigational Site Mobile Alabama 36608 —
Pfizer Investigational Site Northport Alabama 35476 —
Pfizer Investigational Site Little Rock Arkansas 72205 —
Pfizer Investigational Site Oceanside California 92056 —
Pfizer Investigational Site San Diego California 92123 —
Pfizer Investigational Site Santa Rosa California 95405 —
Pfizer Investigational Site Pueblo Colorado 81001 —
Pfizer Investigational Site Hockessin Delaware 19707 —
Pfizer Investigational Site Bradenton Florida 34205 —
Pfizer Investigational Site Brooksville Florida 34601 —
Pfizer Investigational Site Clearwater Florida 33756 —
Pfizer Investigational Site Daytona Beach Florida 32114 —
Pfizer Investigational Site Fort Myers Florida 33912 —
Pfizer Investigational Site Fort Walton Beach Florida 32547 —
Pfizer Investigational Site Maitland Florida 32751 —
Pfizer Investigational Site Melbourne Florida 32901 —
Pfizer Investigational Site Naples Florida 34102 —
Pfizer Investigational Site Ocala Florida 34471 —
Pfizer Investigational Site Orlando Florida 32806 —
Pfizer Investigational Site Plant City Florida 33563 —
Pfizer Investigational Site Port Charlotte Florida 33952 —
Pfizer Investigational Site St. Petersburg Florida 33709 —
Pfizer Investigational Site St. Petersburg Florida 33713 —
Pfizer Investigational Site Tampa Florida 33606 —
Pfizer Investigational Site Atlanta Georgia 30308 —
Pfizer Investigational Site Burr Ridge Illinois 60527 —
Pfizer Investigational Site Elk Grove Village Illinois 60007 —
Pfizer Investigational Site Elkhart Indiana 46514 —
Pfizer Investigational Site Evansville Indiana 47714 —
Pfizer Investigational Site Fort Wayne Indiana 46805 —
Pfizer Investigational Site Greenfield Indiana 46140-2834 —
Pfizer Investigational Site Prairie Village Kansas 66206 —
Pfizer Investigational Site Wichita Kansas 67207 —
Pfizer Investigational Site Lake Charles Louisiana 70601 —
Pfizer Investigational Site New Orleans Louisiana 70114 —
Pfizer Investigational Site Shreveport Louisiana 71105 —
Pfizer Investigational Site Hyannis Massachusetts 02601 —
Pfizer Investigational Site Flowood Mississippi 39232 —
Pfizer Investigational Site Olive Branch Mississippi 38654 —
Pfizer Investigational Site Springfield Missouri 65807 —
Pfizer Investigational Site Great Falls Montana 59405 —
Pfizer Investigational Site Eatontown New Jersey 07724 —
Pfizer Investigational Site Oakhurst New Jersey 07755 —
Pfizer Investigational Site Toms River New Jersey 08755 —
Pfizer Investigational Site Albuquerque New Mexico 87109 —
Pfizer Investigational Site Amherst New York 14226 —
Pfizer Investigational Site Buffalo New York 14211 —
Pfizer Investigational Site Buffalo New York 14215 —
Pfizer Investigational Site Orchard Park New York 14127 —
Pfizer Investigational Site Syracuse New York 13210 —
Pfizer Investigational Site Charlotte North Carolina 28211 —
Pfizer Investigational Site Raleigh North Carolina 27612 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Fargo North Dakota 58103 —
Pfizer Investigational Site Fargo North Dakota 58104 —
Pfizer Investigational Site Cincinnati Ohio 45227 —
Pfizer Investigational Site Oklahoma City Oklahoma 73112 —
Pfizer Investigational Site Portland Oregon 97210 —
Pfizer Investigational Site Altoona Pennsylvania 16602 —
Pfizer Investigational Site Beaver Pennsylvania 15009 —
Pfizer Investigational Site Bridgeville Pennsylvania 15017 —
Pfizer Investigational Site Grove City Pennsylvania 16127 —
Pfizer Investigational Site Indiana Pennsylvania 15701 —
Pfizer Investigational Site Norristown Pennsylvania 19403 —
Pfizer Investigational Site Scotland Pennsylvania 17254 —
Pfizer Investigational Site Upper Saint Clair Pennsylvania 15241 —
Pfizer Investigational Site Charleston South Carolina 29425 —
Pfizer Investigational Site Greer South Carolina 29651 —
Pfizer Investigational Site Murrells Inlet South Carolina 29576 —
Pfizer Investigational Site North Charleston South Carolina 29406 —
Pfizer Investigational Site Orangeburg South Carolina 29118 —
Pfizer Investigational Site Sioux Falls South Dakota 57105 —
Pfizer Investigational Site Franklin Tennessee 37067 —
Pfizer Investigational Site Knoxville Tennessee 37920 —
Pfizer Investigational Site Carrollton Texas 75007 —
Pfizer Investigational Site Fort Worth Texas 76104 —
Pfizer Investigational Site Fort Worth Texas 76117 —
Pfizer Investigational Site Grand Prairie Texas 75050 —
Pfizer Investigational Site Lake Jackson Texas 77566 —
Pfizer Investigational Site Williamsburg Virginia 23185 —
Pfizer Investigational Site Kirkland Washington 98033 —
Pfizer Investigational Site Spokane Washington 99216 —
Pfizer Investigational Site Charleston West Virginia 25304 —
Pfizer Investigational Site La Crosse Wisconsin 54601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00939783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2012 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00939783 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →